All News about Travere Therapeutics Inc
Travere Therapeutics to Present at Upcoming Investor Conferences
February 08, 2023
Via GlobeNewswire
The Latest Analyst Ratings for Travere Therapeutics
January 30, 2023
Via Benzinga
4 Analysts Have This to Say About Travere Therapeutics
December 05, 2022
Via Benzinga
Where Travere Therapeutics Stands With Analysts
December 05, 2022
Via Benzinga
Via Benzinga
Via Benzinga
Travere Therapeutics Provides Corporate Update and 2023 Outlook
January 09, 2023
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
December 12, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 5, 2022
December 05, 2022
Via Benzinga
Travere Therapeutics to Present at Upcoming Investor Conferences
November 09, 2022
Via GlobeNewswire
Travere Therapeutics Reports Third Quarter 2022 Financial Results
October 27, 2022
Via GlobeNewswire
Travere Therapeutics to Report Third Quarter 2022 Financial Results
October 20, 2022
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free